Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Moderate-to-Severe Plaque Psoriasis: The Chinese Healthcare System Perspective

• Main Authors: Jinsui Zhang (Author), Zemin Xia (Author), Wanjie Guo (Author), Xiaoxiao Ren (Author), Fang Liu (Author), Gargi Ratnaparkhi (Author), Amit Pagada (Author), Subhashini Subramanian (Author), Min Hu (Author), Wen Chen (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2023-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction This study assessed the cost-effectiveness of secukinumab compared with other biologics (adalimumab, infliximab, ustekinumab, ixekizumab, guselkumab, and Yisaipu [etanercept biosimilar]) for moderate-to-severe plaque psoriasis from the Chinese healthcare system perspective. Met...